240 related articles for article (PubMed ID: 26718286)
1. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
2. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.
Akbarzadeh M; Movassaghpour AA; Ghanbari H; Kheirandish M; Fathi Maroufi N; Rahbarghazi R; Nouri M; Samadi N
Sci Rep; 2017 Dec; 7(1):17062. PubMed ID: 29213108
[TBL] [Abstract][Full Text] [Related]
3. Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.
Nishiyama M; Tsunedomi R; Yoshimura K; Hashimoto N; Matsukuma S; Ogihara H; Kanekiyo S; Iida M; Sakamoto K; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Ueno T; Hamamoto Y; Hazama S; Nagano H
Cancer Sci; 2018 Apr; 109(4):1101-1109. PubMed ID: 29417690
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells.
Kou J; Gao L; Ni L; Shao T; Ding J
Mol Biotechnol; 2024 May; 66(5):1062-1070. PubMed ID: 38184808
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.
Biddle A; Gammon L; Liang X; Costea DE; Mackenzie IC
EBioMedicine; 2016 Feb; 4():138-45. PubMed ID: 26981578
[TBL] [Abstract][Full Text] [Related]
6. Relationship between CD44
Silva Galbiatti-Dias AL; Fernandes GMM; Castanhole-Nunes MMU; Hidalgo LF; Nascimento Filho CHV; Kawasaki-Oyama RS; Ferreira LAM; Biselli-Chicote PM; Pavarino ÉC; Goloni-Bertollo EM
Am J Cancer Res; 2018; 8(8):1633-1641. PubMed ID: 30210931
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.
Botchkina GI; Zuniga ES; Rowehl RH; Park R; Bhalla R; Bialkowska AB; Johnson F; Golub LM; Zhang Y; Ojima I; Shroyer KR
PLoS One; 2013; 8(9):e69884. PubMed ID: 24086245
[TBL] [Abstract][Full Text] [Related]
8. Anti-ENO1 antibody combined with metformin against tumor resistance: a novel antibody-based platform.
Shu X; Zhang HW; Liu SY; Sun LX; Zhang T; Ran YL
PeerJ; 2024; 12():e16817. PubMed ID: 38515460
[TBL] [Abstract][Full Text] [Related]
9. Human ovarian cancer stem-like cells can be efficiently killed by γδ T lymphocytes.
Lai D; Wang F; Chen Y; Wang C; Liu S; Lu B; Ge X; Guo L
Cancer Immunol Immunother; 2012 Jul; 61(7):979-89. PubMed ID: 22120758
[TBL] [Abstract][Full Text] [Related]
10. Targeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles.
Altundag-Erdogan O; Tutar R; Yüce E; Çelebi-Saltik B
Daru; 2024 May; ():. PubMed ID: 38722566
[TBL] [Abstract][Full Text] [Related]
11. Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells.
Choi YJ; Park JH; Han JW; Kim E; Jae-Wook O; Lee SY; Kim JH; Gurunathan S
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973444
[TBL] [Abstract][Full Text] [Related]
12. Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor.
Chen X; Yan Y; Liu Y; Yi Q; Xu Z
J Nat Prod; 2024 Apr; 87(4):837-848. PubMed ID: 38417401
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic inhibition of Bmi-1 ablates chemoresistant cancer stem cells in adenoid cystic carcinoma.
Sahara S; Warner KA; Herzog AE; Zhang Z; Nör JE
Oral Oncol; 2023 Jul; 142():106437. PubMed ID: 37267716
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR treatment effects on laryngeal cancer stem cells.
Fernandes GMM; Galbiatti-Dias ALS; Ferreira LAM; Serafim Junior V; Rodrigues-Fleming GH; de Oliveira-Cucolo JG; Biselli-Chicote PM; Kawasaki-Oyama RS; Maniglia JV; Pavarino ÉC; Goloni-Bertollo EM
Am J Transl Res; 2021; 13(1):143-155. PubMed ID: 33527014
[TBL] [Abstract][Full Text] [Related]
15. Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression.
Thepthanee C; Ei ZZ; Benjakul S; Zou H; Petsri K; Innets B; Chanvorachote P
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672078
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas.
Cruz SM; Iranpur KR; Judge SJ; Ames E; Sturgill IR; Farley LE; Darrow MA; Crowley JS; Monjazeb AM; Murphy WJ; Canter RJ
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542325
[TBL] [Abstract][Full Text] [Related]
17. Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2.
Zhang K; Hu J; Zhao Z
PLoS One; 2023; 18(7):e0289024. PubMed ID: 37506053
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Tumor Resection and Radiotherapy on the Expression of Stem Cell Markers (CD44 and CD133) in Patients with Squamous Cell Carcinoma.
Paya L; Rafat A; Talebi M; Aghbali A; Shahidi N; Nejati B; Emamverdizadeh P; Nozad Charoudeh H
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):92-99. PubMed ID: 38680713
[No Abstract] [Full Text] [Related]
19. The analysis of boric acid effect on epithelial-mesenchymal transition of CD133 + CD117 + lung cancer stem cells.
Semerci Sevimli T; Sevimli M; Ghorbani A; Şahintürk V; Qomi Ekenel E; Ertem T; Demir Cevizlidere B; Altuğ B; Tomsuk Ö; Uysal O; Güneş Bağış S; Avci H; Çemrek F; Ahmadova Z
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38536434
[TBL] [Abstract][Full Text] [Related]
20. Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells.
Baek JW; Nam AR; Kim K; Kim PH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
